Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016

Lilian T. Gien, Danielle Enserro, Matthew S. Block, Steven Waggoner, Linda Duska, Andrea E. Wahner-Hendrickson, Premal H. Thaker, Floor Backes, Michael Kidd, Carolyn Y. Muller, Paul DiSilvestro, Allan Covens, David M. Gershenson, Kathleen N. Moore, Carol Aghajanian, Robert L. Coleman